Teachers Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Teachers Advisors’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10,410	Closed	-$35K	–	3218
2017 Q1	$35K	Hold	10,410	–	–	﹤0.01%	3040
2016 Q4	$54K	Buy	10,410 +2,478	+31%	+$42.9K	﹤0.01%	3052
2016 Q3	$200K	Hold	7,932	–	–	﹤0.01%	2887
2016 Q2	$196K	Hold	7,932	–	–	﹤0.01%	2905
2016 Q1	$230K	Hold	7,932	–	–	﹤0.01%	2748
2015 Q4	$294K	Buy	7,932 +697	+10%	+$30.8K	﹤0.01%	2720
2015 Q3	$352K	Buy	7,235 +733	+11%	+$51.2K	﹤0.01%	2587
2015 Q2	$448K	Buy	+6,502	New	+$301K	﹤0.01%	2592

Other funds holding ANTH

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Teachers Advisors's ANTH Position: Q2 2017 in Review

Teachers Advisors sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 10,410 shares — an estimated $35K sold.

Teachers Advisors first reported a position in ANTH in Q2 2015 and held it in 8 quarters. The position peaked at $448K in Q2 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

Teachers Advisors reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Teachers Advisors sold 10,410 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $35K.
Teachers Advisors first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 8 quarters.
Teachers Advisors's Anthera Pharmaceuticals, Inc. position peaked at $448K in Q2 2015.
40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.